Scrotal Pain: Clinical Trials

4 trials for Scrotal Pain, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 withdrawn. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Withdrawn 1
Phase 22Completed 1, Withdrawn 1

Follow Scrotal Pain: new trials by email Literature Review of Scrotal Pain trials Research Report on Scrotal Pain

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Transcranial Magnetic Stimulation for Chronic Scrotal Content Pain
Transcranial magnetic stimulation - Scrotal Pain
Phase 1 / Phase 2WithdrawnMedical University of South Carolina2026-09-232026-10-06
Evaluation of the Diagnostic Performance of the Testicular Workup for Ischemia and Suspected Torsion (TWIST) Score for Assessing the Risk of Testicular Torsion in Adult Patients Presenting to the Emergency Department With Scrotal Pain - A Prospective Observational Study
Testicular Torsion, Acute Scrotum
RecruitingUniversity Hospital, Linkoeping10002026-02-012026-04-29
Randomized Control Trial of the Use of Botox to Treat Chronic Scrotal Pain
Botox, Placebo - Scrotal Pain
Phase 2CompletedMount Sinai Hospital, Canada642014-08-012019-03-11
Use of Botox to Treat Scrotal Pain
Botox - Scrotal Pain
Phase 1CompletedMount Sinai Hospital, Canada202013-03-012014-09-01

Narrower conditions

Spermatic Cord Torsion (1)

Broader conditions

Genital Diseases (1)  ·  Genital Diseases, Male (1)  ·  Male Urogenital Diseases (1)  ·  Urogenital Diseases (1)

Interventions

Botulinum Toxins, Type A (2)  ·  Transcranial Magnetic Stimulation (1)  ·  onabotulinum toxin A (1)

Sponsors

Mount Sinai Hospital, Canada (2)  ·  Medical University of South Carolina (1)  ·  University Hospital, Linkoeping (1)

Countries

Canada (2)  ·  Sweden (1)  ·  United States (1)

Top investigators

Keith Jarvi, MD (2)  ·  Jeffery Brockardt, Ph.D. (1)  ·  Jens Wretborn, MD, PhD (1)

NIH funding

2025 (1)